Back to comparisons

Comparison

Omega-3 (DHA/EPA) vs Inositol (Myo-Inositol)

FieldOmega-3 (DHA/EPA)Inositol (Myo-Inositol)
Categoryneuroprotectiveneuroprotective
Dose range1000–3000mg2000–18000mg
Half-life24h
Onset
EvidenceEVIDENCEAEVIDENCEA
Safety●●●●●●●●●●
Legal (US)USOTCUSOTC
PubMed refs52003800

The comparison in plain English

Auto-generated from data

Omega-3 (DHA/EPA) and Inositol (Myo-Inositol) are both in the neuroprotective category respectively. Omega-3 (DHA/EPA) Essential fatty acids critical for brain structure and function. Inositol (Myo-Inositol) Sugar alcohol that functions as a second messenger in cellular signaling.

Bottom line

Omega-3 (DHA/EPA) (evidence A, safety 5/5) matches the evidence base of Inositol (Myo-Inositol) (evidence A, safety 5/5). Omega-3 (DHA/EPA) has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.

Choose Omega-3 (DHA/EPA) if

Omega-3 (DHA/EPA) is the better fit when your goal aligns with its mechanism (DHA (docosahexaenoic acid) is a structural component of neuronal cell membranes, maintaining fluidity and supporting receptor function) and the dose range (1000–3000mg) suits your protocol. Half-life is 24h.

Choose Inositol (Myo-Inositol) if

Inositol (Myo-Inositol) is the better fit when your goal aligns with its mechanism (Functions as a precursor to phosphatidylinositol, a key second messenger system in intracellular signaling) and the dose range (2000–18000mg) suits your protocol. Half-life is —h.

Build a stack with bothOpen builder →
Check interactionsOpen checker →